 MOUNTAIN VIEW, Calif., Dec. 16, 2021 GLOBE NEWSWIRE -- NeuroPace, Inc. Nasdaq: NPCE, a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today announced that Mike Favet, CEO, Rebecca Kuhn, CFO and VP of Finance and Administration, and Irina Ridley, General Counsel and Corporate Secretary will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12th, 2022, at 8:15 am Pacific Time 11:15am Eastern Time. 